Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
VMD to ban some flukicides
Use of certain flukicides to be banned in milk-producing animals

The VMD have announced a ban on the use of certain flukicides in animals producing milk for human consumption. Speaking last week at the Animal Health Distributors Association conference, Paul Green, director of operations at the directorate said the decision had come from the European Commission (EC). The ban aims to "clarify and harmonise" the advice on using these types of products across the member states.

Mr Green said: "The advice confirms that products containing clorsulon, closantel, nitroxinil, triclabendazole and rafoxanide are not authorised for use in animals producing milk for human consumption, including during the dry period."

However, he added that products containing one of these compounds as their sole active substance will be subject to "specific directions", with regards to their use in heifers and ewes prior to the first calving or lambing. For example, clostanel can be given to pregnant cattle, but not during the second half of pregnancy, whereas triclabendazole cannot be used within the year prior to the first lambing or kidding in sheep and goats respectively.

No UK-authorised products contain rafoxanide, and clorsulon is currently only included in UK products in combination with a second active substance, meaning there are no special circumstances with either of these two substances.

According to the directorate, the decision by the EC comes after a "community interest referral", which is a change initiated by concerns regarding the protection of the EU's human and/or animal health. As a result of the decision there will be major changes to the labelling of affected products across the EU. Mr Green said that the marketing authorisation holders (MAHs) concerned were taking the "necessary steps" to introduce the new labelling. Products containing the new advice will start to become available "in about six months time".

More information and a complete list of the specific directions is available on the VMD's website.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk